# Trade Mark Journal No.2026/023 5 June 2026

## UK00004382932 5 May 2026 (5,42,44)

ANIMINIBODY

International priority date claimed: 16 December 2025 (United States of America) (99/549,988)

Class 5
  Veterinary pharmaceutical preparations for the treatment of chronic diseases being viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, and immune related diseases; Therapeutic pharmaceutical for the treatment of chronic diseases being viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, and immune related diseases; Antibodies for veterinary purposes.
Class 42
  Biotechnology research; Research and development in the field of biotechnology; Pharmaceutical research and development; Research and development in the field of veterinary medicine; Research and development in the field of biopharmaceuticals.
Class 44
  Providing veterinary information; Providing health information in the field of chronic diseases; Providing health information; Providing animal health information via a website; Providing information in the field of veterinary medicine.

Animerra, Inc.

Representative: D Young & Co LLP